vs
Side-by-side financial comparison of Grand Canyon Education, Inc. (LOPE) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $308.1M, roughly 1.6× Grand Canyon Education, Inc.). Grand Canyon Education, Inc. runs the higher net margin — 28.1% vs 6.8%, a 21.3% gap on every dollar of revenue. On growth, Grand Canyon Education, Inc. posted the faster year-over-year revenue change (5.3% vs -1.7%). Over the past eight quarters, Grand Canyon Education, Inc.'s revenue compounded faster (5.9% CAGR vs -0.1%).
Grand Canyon Education, Inc. (GCE) is an American for-profit corporation that provides services to universities, specializing in program development, online education, and operational support. Formerly affiliated with Grand Canyon University (GCU), a Christian university in Arizona, GCE became a separate publicly traded company in 2008.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
LOPE vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $308.1M | $493.8M |
| Net Profit | $86.7M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 35.1% | 9.9% |
| Net Margin | 28.1% | 6.8% |
| Revenue YoY | 5.3% | -1.7% |
| Net Profit YoY | 5.9% | 10.5% |
| EPS (diluted) | $3.13 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $308.1M | $493.8M | ||
| Q3 25 | $261.1M | $492.9M | ||
| Q2 25 | $247.5M | $468.8M | ||
| Q1 25 | $289.3M | $458.4M | ||
| Q4 24 | $292.6M | $502.4M | ||
| Q3 24 | $238.3M | $511.2M | ||
| Q2 24 | $227.5M | $504.3M | ||
| Q1 24 | $274.7M | $495.1M |
| Q4 25 | $86.7M | $33.7M | ||
| Q3 25 | $16.3M | $71.7M | ||
| Q2 25 | $41.5M | $39.3M | ||
| Q1 25 | $71.6M | $20.7M | ||
| Q4 24 | $81.9M | $30.5M | ||
| Q3 24 | $41.5M | $19.4M | ||
| Q2 24 | $34.9M | $-153.0M | ||
| Q1 24 | $68.0M | $4.0M |
| Q4 25 | 35.1% | 9.9% | ||
| Q3 25 | 6.9% | 13.8% | ||
| Q2 25 | 20.9% | 12.8% | ||
| Q1 25 | 30.4% | 7.0% | ||
| Q4 24 | 34.2% | 7.8% | ||
| Q3 24 | 20.2% | 6.6% | ||
| Q2 24 | 18.8% | -31.3% | ||
| Q1 24 | 30.8% | 3.2% |
| Q4 25 | 28.1% | 6.8% | ||
| Q3 25 | 6.2% | 14.5% | ||
| Q2 25 | 16.8% | 8.4% | ||
| Q1 25 | 24.8% | 4.5% | ||
| Q4 24 | 28.0% | 6.1% | ||
| Q3 24 | 17.4% | 3.8% | ||
| Q2 24 | 15.3% | -30.3% | ||
| Q1 24 | 24.8% | 0.8% |
| Q4 25 | $3.13 | $0.40 | ||
| Q3 25 | $0.58 | $0.84 | ||
| Q2 25 | $1.48 | $0.46 | ||
| Q1 25 | $2.52 | $0.24 | ||
| Q4 24 | $2.83 | $0.37 | ||
| Q3 24 | $1.42 | $0.23 | ||
| Q2 24 | $1.19 | $-1.84 | ||
| Q1 24 | $2.29 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $111.8M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $746.9M | $865.9M |
| Total Assets | $992.3M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $111.8M | $375.2M | ||
| Q3 25 | $97.3M | $340.1M | ||
| Q2 25 | $192.3M | $224.7M | ||
| Q1 25 | $144.5M | $99.0M | ||
| Q4 24 | $324.6M | $229.9M | ||
| Q3 24 | $263.6M | $103.8M | ||
| Q2 24 | $241.3M | $19.4M | ||
| Q1 24 | $196.2M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $746.9M | $865.9M | ||
| Q3 25 | $758.0M | $890.7M | ||
| Q2 25 | $778.0M | $833.8M | ||
| Q1 25 | $780.7M | $789.2M | ||
| Q4 24 | $783.9M | $764.9M | ||
| Q3 24 | $764.1M | $732.5M | ||
| Q2 24 | $759.2M | $706.5M | ||
| Q1 24 | $759.4M | $856.2M |
| Q4 25 | $992.3M | $2.2B | ||
| Q3 25 | $1.0B | $2.2B | ||
| Q2 25 | $1.0B | $2.1B | ||
| Q1 25 | $1.0B | $2.0B | ||
| Q4 24 | $1.0B | $2.2B | ||
| Q3 24 | $992.9M | $2.1B | ||
| Q2 24 | $992.7M | $2.0B | ||
| Q1 24 | $1.0B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $130.5M | $114.1M |
| Free Cash FlowOCF − Capex | $122.9M | — |
| FCF MarginFCF / Revenue | 39.9% | — |
| Capex IntensityCapex / Revenue | 2.5% | — |
| Cash ConversionOCF / Net Profit | 1.50× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $238.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.5M | $114.1M | ||
| Q3 25 | $-48.6M | $137.3M | ||
| Q2 25 | $124.0M | $137.2M | ||
| Q1 25 | $67.6M | $-117.5M | ||
| Q4 24 | $135.8M | $133.0M | ||
| Q3 24 | $-29.4M | $91.8M | ||
| Q2 24 | $98.6M | $107.0M | ||
| Q1 24 | $85.0M | $-125.2M |
| Q4 25 | $122.9M | — | ||
| Q3 25 | $-58.3M | — | ||
| Q2 25 | $115.4M | — | ||
| Q1 25 | $58.7M | — | ||
| Q4 24 | $126.1M | — | ||
| Q3 24 | $-39.0M | — | ||
| Q2 24 | $89.6M | — | ||
| Q1 24 | $76.0M | — |
| Q4 25 | 39.9% | — | ||
| Q3 25 | -22.3% | — | ||
| Q2 25 | 46.6% | — | ||
| Q1 25 | 20.3% | — | ||
| Q4 24 | 43.1% | — | ||
| Q3 24 | -16.3% | — | ||
| Q2 24 | 39.4% | — | ||
| Q1 24 | 27.7% | — |
| Q4 25 | 2.5% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 3.3% | — |
| Q4 25 | 1.50× | 3.39× | ||
| Q3 25 | -2.99× | 1.91× | ||
| Q2 25 | 2.98× | 3.49× | ||
| Q1 25 | 0.94× | -5.66× | ||
| Q4 24 | 1.66× | 4.36× | ||
| Q3 24 | -0.71× | 4.72× | ||
| Q2 24 | 2.83× | — | ||
| Q1 24 | 1.25× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LOPE
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
